List view / Grid view
20 October 2025 | By
The balance between speed, scale, and compliance has never been more critical. As GLP-1s, biosimilars, and advanced therapies reshape global priorities, pharma leaders face a new question: how can manufacturing infrastructure evolve fast enough to keep pace?
Butterworth Laboratories Ltd is a UK-based contract laboratory providing analytical chemistry services to the global pharmaceutical industry in support of R&D, clinical development and licensed manufacture. We are GLP, GCP and GMP compliant, FDA and MHRA inspected.
As the pioneers of the Limulus amebocyte lysate (LAL) testing methodology, Associates of Cape Cod, Inc., (ACC), specialises in bacterial endotoxin and (1→3)-ß-D-glucan detection, using Food and Drug Association-licensed chromogenic, turbidimetric and gel-clot reagent technologies.
As part of EPR’s Women in Pharma series, Elisabeth Prchla, Managing Director at Merck KGaA, talks to Science Editor Dr Zara Kassam about the secrets of overcoming gender imbalance and harnessing science and innovation...
European Pharmaceutical Review’s roundtable devoted to track and trace technology. Five industry experts focus on how the contribution of track and trace technology is shaping the pharmaceutical sector and explain what factors are driving that change.
In this edition, five leading testing service providers explain how they cater for the pharmaceutical industry’s changing needs.
In this In-Depth Focus; enabling the manufacture of robust biologic drug products, automating biopharmaceutical development, and greater compatibility and ease of use for bioproduction monitoring of monoclonal antibodies.
In this In-Depth Focus; early biotherapeutic lead optimisation for more efficient drug discovery and development, and turning promising compounds into drug candidates.
In this In-Depth Focus; specificity in the recombinant factor C test for endotoxin, the latest trends in pharmaceutical microbiology, and the changing environment in pyrogen and endotoxin testing.
In this issue; recent developments in turning promising compounds into drug candidates, reviewing the latest trends in pharmaceutical microbiology and their implications, and a roundtable debate featuring the views of five industry leaders.
The concept of developing a bioink that can be used for all cell types and all printing techniques is at best unrealistic and at worst impossible. What is much more achievable and also more desirable is a modifiable, modular system...
Recent technological advances are enabling manufacturers to move away from equipment that must be sterilised or consumables that are recycled or pose a risk with their transfer into cleanrooms, towards the adoption of disposable and single-use sterile items. This article considers the advantages of implementing single-use technology and outlines a…
Until drug products can be directly manufactured at their point of use, they will be packaged in container closure systems for storage between manufacturing and use. Until packaging systems for drug products are chemically inert, interactions between a drug product and its packaging will remain the rule and not the…
Kaiser Optical Systems provides Raman analysers and fibre-optic probes for pharmaceutical applications ranging from laboratory discoveries to process control. Working with Kaiser is an opportunity to benefit from its experience and knowledge in Raman spectroscopy, chemometric model development, bioprocessing and pharmaceutical analysis.
Sievers products, now part of SUEZ, meet the needs of the pharmaceutical industry with services ranging from validation support and application expertise, to certified reference materials, custom standards, and on-site services.
In this series, our Science Editor Dr. Zara Kassam, interviews influential decision-makers and female leaders within the pharmaceutical industry, as they discuss their careers, the challenges they’ve faced and the importance of breaking through self-imposed barriers...
